(Reuters) -PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PerkinElmer is taking the pivotal step to focus solely on life sciences and diagnostics and changing its name in the process. To do so, the Waltham, MA-based company announced it was selling its ...

Available on PerkinElmer’s automated GSP® instrument, kit supports early diagnosis by measuring CK-MM concentration instead of CK enzyme activity DMD is an X-linked recessive disease and the most ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Feb. 11, 2021, file photo is the exterior of the PerkinElmer lab in Valencia, Calif. PerkinElmer will spend about ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) today announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science ...

PerkinElmer, Inc. PKI recently completed its buyout of BioLegend for a total consideration of approximately $5.25 billion. The latest buyout, which is historically the largest for the company, is ...

Waltham-based PerkinElmer agreed to sell its Applied, Food, and Enterprise Services businesses to investment firm New Mountain Capital for up to $2.45 billion. The company announced the deal Monday ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...